Small Bone Innovations, Inc. (SBi) today announced that on Sept. 30,
2014 the sale of the assets of its international business, including the
assets of its French, German and Asia Pacific operations, to Stryker
Corporation (NYSE:SYK) was completed.
In a news release issued Aug. 1, 2014, Stryker reported it closed on the
acquisition of substantially all of SBi’s North American assets.
“With its global sales, marketing and distribution resources, Stryker is
well positioned to take SBI’s full range of arthroplasty products to a
much greater patient population, and, in particular, the STAR total
ankle replacement system. The STAR Ankle is the number one total ankle
replacement system in the world and is the only total ankle replacement
system approved for uncemented use through the U.S. Food and Drug
Administration's (FDA) rigorous Premarket Approval (PMA) process. The
Investigational Device Exemption (IDE) study, which was a prerequisite
to obtaining PMA, demonstrated STAR to be 'superior in efficacy and
comparable in safety to fusion.' 1 The IDE and other
subsequent studies show that the STAR ankle has better pain relief,
greater clinical success, less blood loss and a shorter operating time
than fusion. The low profile and bone conserving design favored by
patients combined with its simple, easy to use instrumentation system
favored by surgeons has led to its favorable reception in the
marketplace,” said Anthony G. Viscogliosi, chairman and CEO of SBi.
“We believe the ankle market is at an inflection point of conversion
from fusion to arthroplasty and STAR Ankle will be driving the market as
a product innovator and the most clinically researched total ankle
system in the world. Furthermore, the STAR ankle replacements last long
term and provide relief for patients as demonstrated by the long-term
study conducted by foot and ankle surgeons Jeffrey A. Mann M.D., Roger
A. Mann M.D. and Eric Horton M.D. that reported 91 percent survivorship
at an average follow-up of 9.1 years with 92 percent patient satisfaction2.
1 Charles L. Saltzman et al: 'Prospective
Controlled Trial of STAR, Total Ankle Replacement Versus Ankle Fusion:
Initial Results' Foot & Ankle International/Vol.30, No. 7/July 2009
2
Foot & Ankle International (May 2011 edition, Volume 32 #5
© American Orthopaedic Foot & Ankle Society)
About SBi
Small Bone Innovations, Inc. (SBi) was founded in 2004 by Viscogliosi
Brothers, LLC (VB), the New York-based merchant banking firm that
specializes in the musculoskeletal/orthopedics sector.
SBi was the first company to focus purely on small bones & joints
arthroplasty. It offered a broad, clinically proven portfolio of
products and technologies to treat trauma and diseases in the small
bones & joints. From facilities in Morrisville, Pennsylvania, Péronnas,
France, Donaueschingen, Germany, and Kuala Lumpur, Malaysia, SBi sold
and distributed its products in 41 countries.
For a notice on Forward Looking Statements and more information about
SBi, please visit: www.totalsmallbone.com/us/press.php4.
###
![](http://cts.businesswire.com/ct/CT?id=bwnews&sty=20141006005986r1&sid=ntxv4&distro=nx&lang=en)
Copyright Business Wire 2014